NCT02913794View on ClinicalTrials.gov

Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control

CompletedOBSERVATIONAL
Enrollment

541

Participants

Timeline

Start Date

October 11, 2016

Primary Completion Date

March 29, 2018

Study Completion Date

March 29, 2018

Conditions
Cardiovascular DiseasesHyperlipidemias
Trial Locations (1)

Unknown

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY